Is Acurx Pharmaceuticals LLC (ACXP) overvalued? · $11.3M cap
Acurx Pharmaceuticals LLC (ACXP) is a biotechnology company listed on US.
This page asks whether Acurx Pharmaceuticals LLC (ACXP) looks expensive on cached numbers — not a short thesis.
No cached income statement for ACXP, so there is no earnings base to call rich or cheap.
ACXP currently screens at market cap $11.3M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next ACXP 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the ACXP stock page for the full model, not this heading.
Not investment advice.